| | | |
TTRF
|
|---|
|
Line
|
Treatment
|
Genotype Group
|
Number of Events/n
|
4 yr Fail Rate (95% CI)a %
|
Interaction p-value
|
|---|
|
1
|
Maintenance
|
KIR2DL1+/C2+
|
21/52
|
38 (25–54)
|
0.524
|
|
2
|
Maintenance
|
not KIR2DL1+/C2+
|
7/28
|
30 (15–56)
|
|
3
|
Non-Maintenance
|
KIR2DL1+/C2+
|
18/49
|
38 (26–55)
|
|
4
|
Non-Maintenance
|
not KIR2DL1+/C2+
|
6/30
|
21 (9–43)
|
|
5
|
Maintenance
|
KIR2DL2+/C1+
|
11/36
|
32 (18–53)
|
0.547
|
|
6
|
Maintenance
|
not KIR2DL2+/C1+
|
17/44
|
38 (25–56)
|
|
7
|
Non-Maintenance
|
KIR2DL2+/C1+
|
6/28
|
24 (10–49)
|
|
8
|
Non-Maintenance
|
not KIR2DL2+/C1+
|
18/51
|
36 (24–52)
|
|
9
|
Maintenance
|
KIR2DL3+/C2+
|
17/56
|
33 (21–50)
|
0.982
|
|
10
|
Maintenance
|
not KIR2DL3+/C2+
|
11/24
|
41 (23–64)
|
|
11
|
Non-Maintenance
|
KIR2DL3+/C2+
|
16/60
|
27 (17–43)
|
|
12
|
Non-Maintenance
|
not KIR2DL3+/C2+
|
8/19
|
45 (25–70)
|
|
13
|
Maintenance
|
KIR3DL1+/Bw4+
|
20/54
|
38 (25–55)
|
0.055
|
|
14
|
Maintenance
|
not
KIR3DL1+/Bw4+
|
8/26
|
29 (15–52)
|
|
15
|
Non-Maintenance
|
KIR3DL1+/Bw4+
|
13/50
|
25 (15–41)
|
|
16
|
Non-Maintenance
|
not
KIR3DL1+/Bw4+
|
11/29
|
43 (25–66)
|
- a95% Confidence interval; lines 13-14 (bolded text) had a p-value <0.100 and were analyzed further for associations with outcome
